The Efficacy of Two-Week Quadruple First-Line Therapy with Bismuth, Lansoprazole, Amoxicillin, Clarithromycin onHelicobacter pyloriEradication: A Prospective Study

Optimized Nonbismuth Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With High Rates of Antibiotic Resistance

(2013) Javier Molina–Infante et al.   GASTROENTEROLOGY

Clinical Outcomes of Two-Week Sequential and Concomitant Therapies forHelicobacter pyloriEradication: A Randomized Pilot Study

(2013) Ji Hyun Lim et al.   HELICOBACTER

Effect of Fluoroquinolone Resistance on 14-day Levofloxacin Triple and Triple Plus Bismuth Quadruple Therapy

(2013) Jingxian Liao et al.   HELICOBACTER

Bismuth, moxifloxacin, tetracycline, lansoprazole quadruple first line therapy for eradication of H. pylori: A prospective study

(2013) Bilal Ergül et al.   Clinics and Research in Hepatology and Gastroenterology

Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection

(2012) Alessandro Federico et al.   GASTROENTEROLOGY

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption

(2012) Francis Megraud et al.   GUT

Prevalence of Primary and Secondary Antimicrobial Resistance ofHelicobacter pyloriin Korea from 2003 through 2012

(2012) Jung Won Lee et al.   HELICOBACTER

Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication

(2012) Yao-Kang HUANG et al.   Journal of Digestive Diseases

Quadruple therapy with moxifloxacin and bismuth for first-line treatment ofHelicobacter pylori

(2012) Antonio Francesco Ciccaglione   WORLD JOURNAL OF GASTROENTEROLOGY

Helicobacter pylori Infection

(2011) Deng-Chyang Wu et al.   MEDICINE

Clarithromycin Resistance and Efficacy of Clarithromycin-Containing Triple Eradication Therapy for Helicobacter pylori Infection in Type 2 Diabetes Mellitus Patients

(2011) Mehmet Demir et al.   SOUTHERN MEDICAL JOURNAL

Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial

(2010) M. Romano et al.   GUT

High Efficacy of 14-Day Triple Therapy-Based, Bismuth-Containing Quadruple Therapy for Initial Helicobacter pylori Eradication

(2010) Qinjuan Sun et al.   HELICOBACTER

Should quinolones come first in Helicobacter pylori therapy?

(2010) Marco Berning et al.   Therapeutic Advances in Gastroenterology

Moxifloxacin-Based Triple Therapy Versus Clarithromycin-Based Triple Therapy for First-Line Treatment of Helicobacter pylori Infection: A Meta-Analysis of Randomized Controlled Trials

(2009) Yuan Wenzhen et al.   INTERNAL MEDICINE

Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis

(2008) Alexander C Ford et al.   WORLD JOURNAL OF GASTROENTEROLOGY

“Rescue” regimens after Helicobacter pylori treatment failure

(2008) Javier P Gisbert   WORLD JOURNAL OF GASTROENTEROLOGY